Latest Non-Redemption Agreements: KnightSwan Acquisition Corp.
KnightSwan Acquisition Corp. (KNSW) Adds Non-Redemption Agreement
On July 10, KnightSwan Acquisition Corp. (NYSE:KNSW) and its sponsor entered into a non-redemption agreement with an unaffiliated third party.
Pursuant to the Non-Redemption Agreement, the investor agreed not to redeem an aggregate of 400,000 shares of Class A common stock at the special meeting to approve an extension from July 25, 2023 to July 25, 2024.
In exchange for the foregoing commitment not to redeem such shares, the sponsor has agreed to transfer to the investor an aggregate of 133,200 shares of Class B common stock immediately following consummation of an initial business combination. The Non-Redemption Agreement is not expected to increase the likelihood that the extension proposal is approved by shareholders but will increase the amount of funds that remain in the trust account following the meeting.
READ
Launch Two (NASDAQ:LPBBU) has filed for a $200 million IPO that shows how the market has shifted for new issuance since its sister SPAC Launch One (NASDAQ:LPAAU) filed just over a month ago. Both SPACs are underwritten by Cantor Fitzgerald and seeking nominally the same raise at IPO, but Launch Two is overfunding its trust...
FTAC Emerald (NASDAQ:EMLD) has entered into a definitive agreement to combine with crypto fintech firm Fold at an enterprise value of $381 million. Phoenix, Arizona-based Fold provides digital banking services backed by a treasury of Bitcoin that includes FDIC-secured checking accounts as well Bitcoin trading and awards. The combined company is expected to trade on...
At the SPAC of Dawn Dealmakers remain confident that AI is going to play a big role in their M&A processes, but feel unprepared for some the changes, according to a new survey of 225 corporate and 75 private equity transactions professionals. SS&C subsidiary Mergermarket generated the report that found more than half of respondents...
Trailblazer Merger I (NASDAQ:TBMC) has entered into a definitive agreement to combine with data intelligence firm Cyabra at an enterprise value of $70 million. Tel Aviv-based Cyabra provides tools to corporations and governments to identify fake accounts and combat social media disinformation. The combined company is expected to trade on the Nasdaq once the deal...
Chain Bridge I (NASDAQ:CBRG) has entered into a definitive agreement to combine with cannabinoid pharmaceuticals firm Phytanix Bio at a pre-deal valuation of $58 million. Santa Barbara, California-based Phytanix is working to develop bladder and seizure treatments using cannabis-based substances. The combined company is expected to trade on the Nasdaq under the symbol “PHYX” once...